Breaks Categories: Stock Spotlights

MondayNov 15, 2021 11:58 am

NetworkNewsBreaks – DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF) Empowering Clients to Make Better Decisions Through Actionable Predictive Insight

DigiMax Global (CSE: DIGI) (OTC: DBKSF), a company that provides artificial intelligence (“AI”) and cryptocurrency technology solutions, is emerging as a leader in the AI world. Recently, Harvard Business Review (“HBR”) reported that AI could be instrumental, when combined with analytics, in alleviating skill shortages by creating solutions and augmenting support activities, as well as boosting productivity, delivering new products and services, and addressing supply chain issues. The HBR report predicts that the coming boom in business growth and innovation will be a data-driven one. “Next-generation technologies — artificial intelligence and analytics — will play a key role in boosting business…

Continue Reading

MondayNov 15, 2021 11:28 am

NetworkNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Plans to Develop Next-Generation Hearing Products Following Acquisition

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, recently acquired all assets and operations of iHEAR Medical Inc., a venture-backed pioneer in online direct-to-consumer hearing solutions. INND expects the acquisition to expand and solidify its position as the emerging leader in the market of direct-to-consumer and over-the-counter hearing products. In addition, the acquisition offers InnerScope access to over 40 patents in hearing technology, brings world-class innovation and helps the company broaden its product offering. iHEAR, which has demonstrated a track record of bringing novel hearing solutions to the market, boasts a…

Continue Reading

FridayNov 12, 2021 3:09 pm

NetworkNewsBreaks – Mind Cure Health Inc.’s (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) iSTRYM Opening New Revenue Source, Helping Fuel Further Growth, Expansion

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE”), a leader in advanced proprietary technology and research for psychedelics, recently signed a non-binding letter of intent (“LOI”) with Awakn Life Sciences (NEO: AWKN) (OTCQB: AWKNF), a biotech company with clinical operations researching, developing and delivering psychedelic medicine to treat addiction. “Under the LOI, MINDCURE becomes a distributor of Awakn’s ketamine-assisted psychotherapy for alcohol use disorder in the United States and Canada, through its proprietary digital therapeutics platform, iSTRYM,” reads a recent article. In addition to distributing its partners’ protocols, MINDCURE will also be distributing its own protocols through iSTRYM.…

Continue Reading

FridayNov 12, 2021 11:33 am

NetworkNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Eyeing Q1 2022 Delivery of Highest-Quality Retail Products from Florida Grow Operations

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently completed phase one of an aggressive three-phase development strategy for its Florida facilities, located in Apopka and Sanderson. Phase one entailed the rapid development of the Apopka facility. RWB also announced that it had commenced operation in late September after receiving regulatory approval to begin cultivation. “The initial licensed area in Apopka is capable of producing 85g of flower per plant, translating to projected annual revenue in excess of $10 million. The Apopka facility will supply RWB’s phase two of the strategy, which entails activating thirty 16’ by 40’ customized,…

Continue Reading

FridayNov 12, 2021 11:20 am

NetworkNewsBreaks – Excellon Resources Inc. (NYSE American: EXN) (TSX: EXN) (FSE: E4X2) Reigniting Saxony’s Storied Mining History

Excellon Resources (NYSE American: EXN) (TSX: EXN) (FSE: E4X2) is actively working to reignite the Saxony region’s proud and storied history, which has long been synonymous with silver mining. According to Ben Pullinger, SVP Geology and Corporate Development for Excellon, Saxony has become an important jurisdiction for the company over that past year. “In mid-2020, Excellon announced that it had entered into a research and development alliance with the Helmholtz Institute Freiberg (‘HIF’). The company’s team seeks to apply modern exploration technology on the historically significant Silver City mineral field in Saxony, Germany,” reads a recent article. Excellon, which holds…

Continue Reading

ThursdayNov 11, 2021 1:31 pm

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Enters into Cannabinoid Science

Flora Growth Corp. (NASDAQ: FLGC) recently announced the next stage of its development with the creation of Flora Pharma and the execution of an agreement to begin scientific clinical trials globally. Flora Pharma’s formation follows the acknowledgment and commitment by the management team and board of directors to move ahead with applied research initiatives in medical cannabis in order to become a leader in the discovery, development, manufacturing and commercialization of novel, phytocannabinoid-based prescription medicines and nutraceutical products to address a broad range of diseases. The company also signed an agreement to begin scientific clinical trials on the use of…

Continue Reading

ThursdayNov 11, 2021 1:01 pm

NetworkNewsBreaks – FingerMotion Inc.’s (FNGR) Q2 Results Represent ‘Transition to Greater Profitability’

FingerMotion (OTCQX: FNGR), a communications and big data technology platform builder, recently released its Q2 results. “The China-focused enterprise reported quarterly revenue of $5.39 million, which included a 25% year-over-year quarterly growth in its short and multimedia messaging (‘SMS’ and ‘MMS’) business revenue of $0.73 million,” reads a recent article. According to CEO Martin Shen, the company is seeing unabated growth with SMS texting due to its optimized prepayments of bulk inventory purchases — the subscription plan and mobile phone sales contributed to this growth. FNGR is also seeing strong demand in SMS from its corporate clientele. “Despite the positive…

Continue Reading

ThursdayNov 11, 2021 12:47 pm

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leveraging Partnerships to Facilitate TRP-8803’s Advancement

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) recently announced a collaboration with researchers at the University of Wisconsin-Madison as part of preparations toward planned phase 2b studies. Under the partnership, Dr. Paul Hutson, PharmD, and Dr. Christopher Nicholas, Ph.D., will support clinical pharmacology studies for TRP-8803, Tryp’s proprietary drug formulation with a novel route of administration. Once completed, the studies will provide additional regulatory support for TRP-8803. The pair will also serve as investigators on a clinical pharmacology study to evaluate the safety and pharmacokinetics of TRP-8803. “This partnership is the latest in a series of collaborations with scholars, institutions and…

Continue Reading

ThursdayNov 11, 2021 12:32 pm

NetworkNewsBreaks – Why Cannabis Strategic Ventures Inc. (NUGS) Is ‘One to Watch’

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, is guided by the vision to acquire and scale assets in the legal cannabis market while achieving efficiencies through economies of scale and vertical integration. “Cannabis Strategic Ventures recently expanded its portfolio by completing the transfer process for cultivation, retail, distribution and manufacturing licenses issued by the city of Los Angeles and the state of California, and it is now working toward taking operational control of each license,” reads a recent article. Its brand portfolio includes NUGS, the NUGS Farm North and MDRN Tree. NUGS provides emerging…

Continue Reading

WednesdayNov 10, 2021 2:33 pm

NetworkNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Eyeing Opportunities in the US, UK and EU, Generating Interest Among Latin American and Caribbean Countries

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) was featured in a recent “Bell2Bell” podcast episode in which CEO Hector Bremner discussed the company’s history, its goals and the plans it has for development further down the road. “Avricore’s flagship HealthTab(TM) platform partners currently with Abbott Rapid Diagnostics’ Afinion 2(TM) and ID Now(TM) analyzers, as well as Abaxis Global Diagnostics’ Piccolo Xpress to conduct blood or molecular testing at a neighborhood pharmacy and then shares the data from tests not only with the patient but also with medical professionals and researchers without compromising health privacy,” reads a recent article. Avricore accomplished the…

Continue Reading